Dr. Gillian Currie

Associate Director, Health Economics Research (with Dr. Deborah Marshall’s Team)

Adjunct Associate Professor, Departments of Paediatrics and Community Health Sciences


Dr. Gillian Currie is a health economist at the University of Calgary. Her PhD in Economics from Yale University was funded by the Social Sciences and Humanities Research Council of Canada.  She was recruited as a Postdoctoral Fellow in Health Economics to the University of Calgary in 1999 by the inaugural Svare Chair in Health Economics (Dr. Cam Donaldson). Gillian was the Section Lead for the Research Methods Team, an academic section within the Department of Paediatrics, from 2006-2016.  She is a member of both Alberta Children’s Hospital Research Institute for Child and Maternal Health (ACHRI) and the O’Brien Institute of Public Health.

Dr. Currie has made significant educational contributions in the Department of Community Health Sciences including developing and introducing courses, teaching graduate courses, supervising graduate students at the PhD and MSc levels, and serving on the Graduate Education Committee (GEC) in the Department of Community Health Sciences. As the Health Services Research (and later Health Economics) specialization GEC representative, she led the group in the development and introduction of the specialization MSc and PhD in Health Economics which was formally introduced in 2013.


Dr. Currie’s research interests are in economic evaluation, particularly of interventions and treatments that impact the health of children. Specifically, she is interested in methods to understand how we value the benefits of those interventions via stated preference elicitation methods.  Current key research projects are:  examining the cost-effectiveness of body-checking policies in youth hockey; examining the cost-effectiveness of precision medicine approaches to tailored drug treatment in juvenile idiopathic arthritis; measuring parent and child preferences for tapering/stopping biologic medications for juvenile idiopathic arthritis.